| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 0 | 467 | 113.573 | 129.352 | 163.411 |
| Total Income - EUR | - | - | 0 | 1.700 | 1.627 | 1.294 | 467 | 118.674 | 133.173 | 168.149 |
| Total Expenses - EUR | - | - | 4.827 | 2.230 | 852 | 404 | 40.813 | 37.345 | 67.611 | 71.378 |
| Gross Profit/Loss - EUR | - | - | -4.827 | -531 | 775 | 890 | -40.346 | 81.329 | 65.561 | 96.771 |
| Net Profit/Loss - EUR | - | - | -4.827 | -531 | 775 | 890 | -40.346 | 80.138 | 64.308 | 93.092 |
| Employees | - | - | 1 | 1 | 0 | 0 | 0 | 3 | 4 | 5 |
Check the financial reports for the company - Bioavellane Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 230.081 | 305.239 | 335.194 | 351.140 |
| Current Assets | - | - | 69 | 829 | 1.727 | 2.584 | 657 | 25.870 | 26.194 | 28.537 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 238 | 166 | 221 | 551 | 25.165 | 13.764 | 7.930 |
| Cash | - | - | 69 | 591 | 1.561 | 2.363 | 105 | 704 | 12.430 | 20.607 |
| Shareholders Funds | - | - | -4.783 | -5.226 | -4.349 | -3.377 | -43.649 | 36.354 | 64.357 | 157.090 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.852 | 6.055 | 6.077 | 5.961 | 274.387 | 294.755 | 297.032 | 220.123 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.464 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Bioavellane Srl